FCFC
GILD icon

First Citizens Financial Corp’s Gilead Sciences GILD Stock Holding History

First Citizens Financial Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
1,850
+169
+10% +$22.3K 0.1% 126
2026
Q1 		$234K Buy
+1,681
New +$235K 0.11% 125

Other funds holding GILD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

First Citizens Financial Corp's GILD Position: Q2 2026 in Review

First Citizens Financial Corp increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $22.3K and bringing the position to 1,850 shares worth $234K. The position accounts for 0.1% of the portfolio, ranked #126.

First Citizens Financial Corp first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $234K in Q1 2026. 1,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First Citizens Financial Corp held 1,850 shares of Gilead Sciences worth $234K as of Q2 2026.
  • First Citizens Financial Corp bought 169 Gilead Sciences shares in Q2 2026, an estimated $22.3K.
  • Gilead Sciences made up 0.1% of First Citizens Financial Corp's portfolio in Q2 2026, its #126 holding.
  • First Citizens Financial Corp first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • First Citizens Financial Corp's Gilead Sciences position peaked at $234K in Q1 2026.
  • 1,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First Citizens Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.